ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Detection and Characterization of Residual Masses in Lymphomas
- Status
- COMPLETED
- Phase
- N/A
Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD
- Status
- COMPLETED
- Phase
- PHASE2
Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma.
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1
Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease.
- Status
- COMPLETED
- Phase
- PHASE2
Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Intra-Osseous Co-Transplant of UCB and hMSC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE4
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1